Skip to content
Abierto
Menu

Award notice

Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)

75A50124C00046

Office of Assistant Secretary for Preparedness and Response, Barda - Aspr / Daappo / Barda DCMA. Research and Development in Biotechnology (except Nanobiotechnology).

View on SAM.govMarkdown

Awarded

Cerus Corporation

$248,591,407.65 on the award notice, September 23, 2024, contract 75A50124C00046

Description

As published on SAM.gov.

License pathogen reduction technology (PRT) for red blood cell (RBC) components to reduce the risk of transfusion-transmitted infection (TTI) by recognized emerging, epidemic, and endemic pathogens that is capable of treating over 10 million RBC components per year.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Cerus Corporation
UEI
KJJQRRLY2FL5
CAGE
1PVJ6
Vendor location
Concord, CA
Contract
75A50124C00046, definitive contract
Obligated
$65,358,563.95, potential $209,038,158
Actions
4 between September 20, 2024 and July 21, 2026
Competition
Full and Open Competition, 1 offer received
Set-aside reported
No Set Aside Used.
Described as
License Pathogen Reduction Technology (Prt) for Red Blood Cell (Rbc) Components to Reduce the Risk of Transfusion-Transmitted Infection (Tti) by Recognized, Emerging, Epidemic, and Endemic Pathogens That Is Capable of Treating Over 10 Million RBC Com
Match
award number 75A50124C00046 equals the contract number; same awarding office 75A501 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. October 7, 2024

    Award notice, originally solicitation

    Awarded to CERUS CORPORATION Concord for $248,591,408. SAM.gov, notice dd5785c70ab7460c970270efb9eef18c

Points of contact

Also open from this buyer